bioAffinity Technologies, Inc. (BIAF) Stock Analysis

bioAffinity Technologies, Inc. (BIAF) is a publicly traded company in the HEALTHCARE sector. It trades at $1.68, carries a market capitalization of $7.94M. This page summarizes the public market data, fundamentals, and frequently asked questions for BIAF, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DIAGNOSTICS & RESEARCH

Exchange: NASDAQ

Key Metrics

• Price: $1.68
• Market Cap: $7.94M
• EPS: $-4.67
• 52-Week High: $13.80
• 52-Week Low: $0.69

Market Sentiment

bioAffinity Technologies, Inc. currently has a Bullish sentiment score of 0.42.

About bioAffinity Technologies, Inc.

bioAffinity Technologies, Inc. (BIAF) is a pioneering biotechnology company headquartered in San Antonio, Texas, dedicated to revolutionizing cancer diagnostics and treatment. Leveraging its proprietary non-invasive technologies, the firm focuses on enhancing early detection and targeted therapies to improve patient outcomes in oncology. With a strong commitment to innovation and research, bioAffinity is well-positioned to address significant challenges in cancer care, aiming to make meaningf...

GNG Research Analysis

GNG Research scores bioAffinity Technologies, Inc. (BIAF) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for BIAF.

Frequently Asked Questions

Does BIAF pay dividends?

bioAffinity Technologies, Inc. (BIAF) does not currently pay a regular dividend.

What is BIAF's market cap?

bioAffinity Technologies, Inc. (BIAF) has a market capitalization of $7.94M with a current stock price of $1.68.